Stroke and bleeding with non-vitamin K antagonist oral anticoagulant or warfarin treatment in patients with non-valvular atrial fibrillation: a population-based cohort study
ConclusionThis population-based cohort study of routine care indicates similar or better effectiveness and safety with NOAC compared with warfarin treatment. NOACs were associated with fewer intracranial bleeds, but more gastrointestinal bleeds.
Source: Europace - Category: Cardiology Source Type: research
More News: Atrial Fibrillation | Bleeding | Coumadin | Gastroenterology | Hemorrhagic Stroke | Ischemic Stroke | Primary Care | Stroke | Study | Vitamin K | Vitamins | Warfarin